scPharmaceuticals Inc (SCPH)
4.61
+0.19
(+4.30%)
USD |
NASDAQ |
Sep 27, 16:00
4.62
+0.01
(+0.22%)
After-Hours: 20:00
scPharmaceuticals Gross Profit (Quarterly): 5.754M for June 30, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.754M |
| March 31, 2024 | 4.317M |
| December 31, 2023 | 4.323M |
| September 30, 2023 | 2.717M |
| June 30, 2023 | 1.284M |
| Date | Value |
|---|---|
| March 31, 2023 | 1.458M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2022
5.754M
Maximum
Jun 2024
1.985M
Average
1.371M
Median
Gross Profit (Quarterly) Benchmarks
| Verrica Pharmaceuticals Inc | 4.635M |
| NovaBay Pharmaceuticals Inc | 1.592M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |